Results for tag: "Fibrosis Drug"

The Fibrosis Drug market is a subset of the Musculoskeletal Disorders Drugs market, which focuses on treatments for conditions that affect the bones, muscles, and joints. Fibrosis drugs are used to treat a variety of conditions, including rheumatoid arthritis, lupus, and osteoarthritis. These drugs are designed to reduce inflammation, improve joint mobility, and reduce pain. They can also be used to slow the progression of fibrosis, a condition in which the body produces too much collagen, leading to scarring and stiffness. The Fibrosis Drug market is highly competitive, with a range of products available from both large pharmaceutical companies and smaller biotechnology firms. Companies in the market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more